Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba, Mónica Del Rey, Kamila Janusz, Eva Lumbreras, María Abáigar, Robledo Cristina, Andrés Jerez, Esperanza Such, Guillermo Sanz, Cristina Calderon, David Valcarcel, Jesus Maria Hernandez- Rivas, María Consuelo Cañizo, and María Díez-Campelo Blood Volume 126(23): December 3, 2015 ©2015 by American Society of Hematology
Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology
Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology
Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology